In patients who cannot take warfarin, the combination of clopidogrel and aspirin reduced major vascular events, particularly stroke, although at the expense of an increase in major bleeding.
Medscape Medical News
Strong clinical communication skills can help address the disparities in diagnosis and treatment faced by minority patients with psychosis. Watch the videos in this article to learn more.
Medscape Psychiatry & Mental Health
This clinical update provides a review of antiepileptic drugs (AEDs) for the treatment of partial epilepsy, including available first- and second-generation AEDs and emerging AEDs.
Medscape Neurology & Neurosurgery
Healthcare costs are more than 3 times higher for people with Alzheimer's disease and various dementias than for others age 65 years and older, experts suggest.
Medscape Medical News
Results of a small feasibility study with the Rheos hypertension system, a new implantable device that activates the baroreceptors of the carotid sinus, show that it produces significant reductions in blood pressure in patients with refractory hypertension.
Heartwire
A phase 2 trial described as being the critical first step on the journey to discover whether a polypill could work effectively has shown just that. The pill, with five components, could cut cardiovascular risk by half, say the researchers.
Heartwire
A new study has shown that a surprising 37% of subarachnoid-hemorrhage patients met the diagnostic criteria for posttraumatic stress disorder.
Medscape Medical News
Explore the latest rationale for antithrombotic therapy selection in stroke/TIA prevention so as to optimally incorporate into clinical practice.
A proof-of-concept study in 45 patients with resistant hypertension suggests that a brief catheter-based procedure can ablate renal sympathetic nerves and may provide persistent blood-pressure reduction.
Medscape Medical News
Investigators say the initial intervention for the low-risk primary-prevention patient remains lifestyle and dietary modifications, but for clinicians choosing drug therapy, reductions in both LDL cholesterol and hs-CRP are indicators of the success of treatment with statin therapy.
Heartwire